Scientists develop groundbreaking dual-action drug RI-AG03 that targets toxic tau proteins in Alzheimer's disease, showing ...

All applications must fall within Alzheimer’s Research UK’s remit which covers biomedical research in Alzheimer’s disease and other dementias. Alzheimer’s Research UK funds research into treatment, ...

Matt Price drove his 73-year-old father Stephen from their New Jersey home to a medical strip mall on the Jersey Shore, for his first injection of an experimental drug called ...

Whether you're curious to explore a healthy brain or brains affected by Alzheimer’s disease, vascular dementia, dementia with Lewy bodies, or Frontotemporal dementia, the choice is yours. Tailoring ...

However, we still see areas of weakness in the portfolio, including upcoming patent losses and a highly uncertain pipeline due to the complexities of running CNS trials. Historically, the firm ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

In collaboration with Prof. Min-Kyung Baek's research team, LG AI Research aims to develop an AI model for protein multistate structure prediction by the end of the year, addressing current ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...

SAN ANTONIO – A new study from UT Health San Antonio has provided new insights into Alzheimer’s disease. Researchers have uncovered a genetic factor that may contribute to the risk of late onset of ...

Research supporting the amyloid hypothesis—the idea that Alzheimer's is caused by a buildup of amyloid plaques in the ...

A new study suggests that getting more than six hours of good-quality sleep each night may help slow down or even prevent the ...

Children who inherit genetic mutations from parents with early-onset Alzheimer’s typically show signs of dementia at the same ...